baito logo
    navigation?.buttons?.createJob?.text
    Fire
    new
    Cancilico GmbH header
    Cancilico GmbH logo
    #kiinmedizin #hämatologie #krebsdiagnostik

    Cancilico GmbH

    from Dresden

    Cancilico develops AI-based software for medical diagnostics, especially for the detection of hematological cancers. The innovative start-up improves patient care through more precise and efficient diagnostic procedures.

    Visit websiteArrowRight

    Cancilico is an innovative start-up company that specializes in the integration of artificial intelligence (AI) into image-based diagnostics in the medical field. Founded by an interdisciplinary team of business information scientists, computer scientists, biologists and physicians, Cancilico pursues the mission of significantly improving and accelerating the diagnosis of hematological cancers. The focus is on the development of AI-supported software solutions that not only automate traditional diagnostic methods, but also make them significantly more accurate and efficient[1][2].

    The core product of Cancilico is the AI-based software MyeloAID, which was developed specifically for hematological diagnostics. This solution supports medical professionals in efficiently evaluating complex image data from clinical examinations and thus enables precise identification of cancer cells in the bone marrow and other blood samples. By automating repetitive diagnostic steps, medical personnel gain valuable time for individual patient care and in-depth research[3][4].

    Cancilico attaches great importance to a close integration of cutting-edge research and practical application, which is reflected in the cooperation with renowned research institutions such as the National Center for Tumor Diseases (NCT) in Dresden. The company is supported, among other things, by EU and state funding, which underlines the high level of innovation and relevance of its work[2][4].

    The values of Cancilico are based on the aspiration to improve the quality of life of patients through technological innovations and to make medical care fit for the future. A particularly important aspect is the promotion of the accessibility and traceability of diagnostic procedures through intelligent, user-friendly technologies. Sustainability is demonstrated here not only in the optimization of medical resources and work processes, but also in the long-term improvement of therapy success through precise and early diagnosis[1][3].

    In addition, Cancilico is committed to the continuous development and research of new AI algorithms in order to always remain at the forefront of medical innovation. The aim is to expand the AI application in diagnostics to further clinical pictures and thus provide even more comprehensive support for the healthcare industry in the future[3].

    Overall, Cancilico stands for a forward-looking combination of artificial intelligence with medical diagnostics, which not only increases the efficiency and accuracy of disease detection, but also makes a significant contribution to improving patient care and medical research.

    Quellen:

    Edit
    Edit